Are we ready for precision medicine for Autism? And who wants it?
Author:
- 11 April 2021
- journal article
- editorial
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 48, 32-33
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- From pattern classification to stratification: towards conceptualizing the heterogeneity of Autism Spectrum DisorderNeuroscience & Biobehavioral Reviews, 2019
- Big data approaches to decomposing heterogeneity across the autism spectrumMolecular Psychiatry, 2019
- Cortical and Subcortical Brain Morphometry Differences Between Patients With Autism Spectrum Disorder and Healthy Individuals Across the Lifespan: Results From the ENIGMA ASD Working GroupAmerican Journal of Psychiatry, 2018
- What evidence do we need for biomarker qualification?Science Translational Medicine, 2017
- A Meta-Analysis of Gaze Differences to Social and Nonsocial Information Between Individuals With and Without AutismJournal of the American Academy of Child & Adolescent Psychiatry, 2017
- Considerations in biomarker development for neurodevelopmental disordersCurrent Opinion in Neurology, 2016
- Identification and validation of biomarkers for autism spectrum disordersNature Reviews Drug Discovery, 2015
- The NIMH Research Domain Criteria (RDoC) Project: Precision Medicine for PsychiatryAmerican Journal of Psychiatry, 2014